QNCX

Quince Therapeutics Inc
1.00
0.0551 (5.83%)

Quince Therapeutics Inc. (QNCX) Fundamentals

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.
SHARE INFORMATION
Market Cap$ 34,139,526
Shares Outstanding36,130,306
Float25,469,285
Percent Float70.49%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -3.03
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions204
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months461,274
Institutional Holdings Percent36.1%
Institutional Sold Previous 3 Months4,734,507
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent6.9
Insider Sold Previous 3 Months1,640
Insider Shares Owned2,478,200
TRADING INFO
52 Week High$ 6.85
52 Week Low$ 0.54
52 Week High Change$ -84.66
21 Day Moving Average$ 0.8099
21 Day Extended Moving Average$ 0.834423
50 Day Moving Average$ 0.7329
50 Day Extended Moving Average$ 0.822349
200 Day Moving Average$ 1.7578
200 Day Extended Moving Average$ 4.4774
10 Day Average Volume7,062,361
20 Day Average Volume3,610,070
30 Day Average Volume2,522,217
50 Day Average Volume1,611,696
Alpha-0.017753
Beta1.2596
Standard Deviation0.348549
R20.042177
7 Day Price Change$ 0.1369
7 Day Percent Change16.94%
21 Day Price Change$ 0.1649
21 Day Percent Change21.14%
30 Day Price Change$ 0.3075
30 Day Percent Change48.24%
Month to Date Price Change$ -0.0351
Month to Date Percent Change-3.58%
Quarter to Date Price Change$ 0.3075
Quarter to Date Percent Change48.24%
180 Day Price Change$ -0.9651
180 Day Percent Change-50.53%
200 Day Price Change$ -1.23
200 Day Percent Change-56.46%
Year to Date Price Change$ 0.3075
Year to Date Percent Change48.24%

Quince Therapeutics Inc. (QNCX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.40
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio19.90
Leverage Ratio1.10
Quick Ratio19.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.40
Enterprise Value$ -59,815,992
Price to Sales0.00
Price to Free Cash-1.20
PE High Last 5 Years0.00
Price To Book0.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-54.06
Return on Equity-58.63
Return on Capital-58.82

Quince Therapeutics Inc. (QNCX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBDO USA, LLP
CEODirk Thye
Emplyoees55
Last AuditUQ
CIK0001662774
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address269 East Grand Avenue
Suite 1250
South San Francisco, CA 94080
Websitehttps://www.cortexyme.com
Facsimile-
Telephone+1 415 910-5717
Email-


Your Recent History
NASDAQ
QNCX
Quince The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.